In today’s healthcare industry, the costs to develop a product are higher than ever before. Research & Development departments focus only on clinical benefits, often leading to sub-optimal commercialization for pharmaceutical firms. Therefore, it is important to optimize R&D efforts by focussing on commercially attractive therapy areas with manageable access hurdles.
At phamax, we help to identify the value of the product at the early stages of the R&D planning by including market access considerations. Our early market access services link the market potential with access requirements, bridging the gap between R&D and Commercial departments for the successful planning of your product.
As our key differentiator, we bring in scientific know-how through our in-house physician team, the Focus Scientific Research Center (FSRC), with access to over 2000 healthcare stakeholders across the globe, supporting your strategy with insights from key medical experts.
In this way, we help you streamline your product development by reducing time and costs, while preparing you for a successful launch.